Melanoma treatment update at ASCO 2015

Axel Hauschild, MD, of University of Schleswig-Holstein, Kiel, Germany, reviews the clinical trial data for new treatments in melanoma presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. He highlights trials on combined BRAF and MEK inhibition versus BRAF inhibition alone, and immunotherapy drug combinations.

Year of Production:
Running Time:
Color/Sound:

2015
04:55
Color/Sound

Comments are closed.